logo
ResearchBunny Logo
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7

Medicine and Health

Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7

V. Bandara, J. Foeng, et al.

Discover the groundbreaking potential of CAR-T cell immunotherapy targeting nfP2X7, a novel treatment that can revolutionize the fight against solid tumors. This innovative study demonstrates the construct's ability to eliminate cancer cells while sparing healthy tissue, as shown by Veronika Bandara, Jade Foeng, Batjargal Gundsambuu, and their colleagues at the University of Adelaide.

00:00
00:00
~3 min • Beginner • English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Related Publications

Explore these studies to deepen your understanding of the subject.

A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma
Medicine and Health

A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma

A. Rezapour, D. Rydbeck, et al.

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial
Medicine and Health

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

T. B. Dorff, M. S. Blanchard, et al.

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial
Medicine and Health

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial

T. Sonoda, Y. Umeda, et al.

Locoregional delivery of IL-13Rx2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
Medicine and Health

Locoregional delivery of IL-13Rx2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

C. E. Brown, J. C. Hibbard, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny